Hajduk Philip J, Mendoza Renaldo, Petros Andrew M, Huth Jeffrey R, Bures Mark, Fesik Stephen W, Martin Yvonne C
Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, IL 60044, USA.
J Comput Aided Mol Des. 2003 Feb-Apr;17(2-4):93-102. doi: 10.1023/a:1025305520585.
A detailed chemometric analysis of ligand binding to domain-3A of human serum albumin is described. NMR and fluorescence data on a set of 889 chemically diverse compounds were used to develop a group contribution model based on 74 chemical fragments that is in good agreement with the experimental data (R2 = 0.94, Q2 = 0.90). The structural descriptors used in this analysis comprise a convenient look-up table for quantitatively estimating the effect that a particular group will have on albumin binding. This information can be valuable for optimizing a particular series of compounds for drug development.